DAWN: Day One Biopharmaceuticals Inc Company Profile & Statistics

About

Day One Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It dedicated to developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Day One Biopharmaceuticals Inc. is based in SOUTH SAN FRANCISCO, Calif.

Info & Links

CEO

Jeremy Bender

Headquarters

2000 Sierra Point Parkway, Suite 501
Brisbane, CA 94005, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

87,384,860

Employees

155

Day One Biopharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization²

1.27B

Enterprise Value

850.97M

Enterprise Value/EBITDA(ttm)

-4.05

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

2.31

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

47.42%

Operating Margin(ttm)

Profit Margin(ttm)

-3.57%

Return on Equity(ttm)

-22.40%

Return on Invested Capital(ttm)

-31.53%

Return on Assets(ttm)

-19.79%

Income Statement

Revenue(ttm)

101.95M

Revenue Per Share(ttm)

1.01

Gross Profit(ttm)

99.66M

EBITDA(ttm)³

-210.08M

Net Income Available to Common(ttm)

-84.29M

Diluted EPS(ttm)

-1.03

Share Statistics

Beta (5Y Monthly)

-1.51

52-Week Change

3.87%

S&P 500 52-Week Change

27.63%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

100.85M

Dividend Yield

0.00%

Float⁴

92.38M

% Held by Insiders

8.40%

% Held by Institutions

87.95%

Balance Sheet

Total Cash(mrq)

558.38M

Total Cash Per Share(mrq)

5.54

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

14.62%

Quick Ratio(mrq)

14.55%

Book Value Per Share(mrq)

5.51

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.50

Free Cash Flow(ytd)

-48.85M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

DAWN

Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals Inc Profile